Stocks Cool Off From Last Week's Rally

A cooling tech sector has the Nasdaq down triple digits

Deputy Editor
Nov 14, 2022 at 11:58 AM
facebook twitter linkedin

Stocks are starting the week off lower, unable to build off of last week's impressive rally. The Nasdaq Composite (IXIC) is down triple digits at midday as the tech sector takes a breather, while the Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) sit more modestly in the red.

Meanwhile, gold prices are inching higher and are holding at their highest levels since August. Investors are also unpacking comments from Fed Vice Chair Lael Brainard, who told Bloomberg news “I think it will probably be appropriate soon to move to a slower pace of rate increases.”

Continue reading for more on today's market, including:

  • Struggling Amazon stock loses "best idea" status. 
  • Analysts can't get enough of this semiconductor stock
  • Plus, options bulls target MLCO; two biotech stocks moving in different directions. 

MMC Nov14

Shoals Technologies Group Inc (NASDAQ:SHLS) is seeing a bearish options surge ahead of its third-quarter report, due out after the close today. So far, 7,792 puts and 564 calls have crossed the tape, with put volume running at 18 times the intraday average. The stock has been getting turned away at the $24 level, though its 200-day moving average has been offering support just above $18. Year-over-year, the stock is down 36.1%. 

SHLS Nov14

Opiant Pharmaceuticals Inc (NASDAQ:OPNT) is at the top of the Nasdaq today, up 113.6% at $20.29 at last glance, after news that Indivior Inc, a subsidiary of Indivior PLC (INDV) has offered to buy the company in a deal valued at $28 per share. The merge is approved by both companies and is awaiting regulatory approval. Now trading at its highest level since May, the equity is still down 39.4% year-to-date. 

Meanwhile, POINT Biopharma Global Inc (NASDAQ:PNT) is down 35.4% at $5.90 and on the short sell restricted (SSR) list, after news that the company has signed collaboration agreements with Lantheus Holdings (LNTH) for PNT2002 and PNT2003, its late-stage cancer therapy drug candidates. Year-to-date, PNTH is still up 6.7%.  


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners